Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder | 20 | 2022 | 1151 | 4.030 |
Why?
|
| Urothelium | 9 | 2017 | 269 | 2.700 |
Why?
|
| Cystitis | 4 | 2022 | 95 | 1.570 |
Why?
|
| Ketamine | 5 | 2022 | 517 | 1.410 |
Why?
|
| Receptors, Purinergic P2Y12 | 2 | 2019 | 115 | 1.090 |
Why?
|
| Urination | 4 | 2017 | 201 | 1.080 |
Why?
|
| Muscle, Smooth | 6 | 2022 | 927 | 0.990 |
Why?
|
| Urinary Bladder, Overactive | 3 | 2022 | 114 | 0.900 |
Why?
|
| Muscle Contraction | 6 | 2022 | 1200 | 0.880 |
Why?
|
| Calcium Channels, L-Type | 2 | 2022 | 242 | 0.860 |
Why?
|
| Urodynamics | 5 | 2021 | 344 | 0.830 |
Why?
|
| Receptors, Purinergic P2 | 2 | 2013 | 150 | 0.780 |
Why?
|
| Urinary Retention | 1 | 2021 | 106 | 0.700 |
Why?
|
| Receptor, Adenosine A2B | 1 | 2019 | 34 | 0.670 |
Why?
|
| Mechanotransduction, Cellular | 3 | 2015 | 528 | 0.650 |
Why?
|
| Calcium Channel Blockers | 1 | 2022 | 694 | 0.610 |
Why?
|
| Receptors, Purinergic P2X4 | 1 | 2018 | 21 | 0.610 |
Why?
|
| Adenosine Triphosphatases | 3 | 2015 | 835 | 0.520 |
Why?
|
| Adenosine Diphosphate | 1 | 2014 | 422 | 0.440 |
Why?
|
| Receptors, Purinergic P2X1 | 1 | 2013 | 8 | 0.430 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2013 | 110 | 0.420 |
Why?
|
| Interstitial Cells of Cajal | 1 | 2012 | 23 | 0.420 |
Why?
|
| Stress, Mechanical | 2 | 2015 | 1674 | 0.400 |
Why?
|
| Type C Phospholipases | 1 | 2013 | 287 | 0.400 |
Why?
|
| Adenosine Triphosphate | 2 | 2015 | 1988 | 0.390 |
Why?
|
| Muscle Cells | 1 | 2012 | 195 | 0.390 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2011 | 68 | 0.370 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2014 | 540 | 0.370 |
Why?
|
| Myofibroblasts | 1 | 2012 | 223 | 0.370 |
Why?
|
| Drug Delivery Systems | 1 | 2022 | 2222 | 0.350 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2010 | 130 | 0.330 |
Why?
|
| Adenosine | 1 | 2014 | 805 | 0.330 |
Why?
|
| Behavior, Animal | 1 | 2017 | 1872 | 0.330 |
Why?
|
| Mice | 18 | 2022 | 81368 | 0.310 |
Why?
|
| Animals | 24 | 2022 | 168201 | 0.280 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 18221 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 8 | 2019 | 22115 | 0.260 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2006 | 108 | 0.260 |
Why?
|
| Mice, Knockout | 6 | 2020 | 14389 | 0.250 |
Why?
|
| Antibodies | 1 | 2013 | 2414 | 0.240 |
Why?
|
| Exocytosis | 1 | 2006 | 320 | 0.240 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 5835 | 0.230 |
Why?
|
| Cell Membrane | 2 | 2014 | 3680 | 0.220 |
Why?
|
| Signal Transduction | 4 | 2020 | 23416 | 0.220 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2022 | 37 | 0.210 |
Why?
|
| Cytoskeleton | 2 | 2008 | 1170 | 0.190 |
Why?
|
| TRPV Cation Channels | 2 | 2011 | 243 | 0.160 |
Why?
|
| Urinary Bladder Diseases | 1 | 2019 | 167 | 0.160 |
Why?
|
| Receptor, Insulin | 1 | 2022 | 836 | 0.160 |
Why?
|
| Xenopus | 1 | 2020 | 711 | 0.150 |
Why?
|
| Kidney | 3 | 2020 | 7045 | 0.150 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2019 | 269 | 0.140 |
Why?
|
| Adiponectin | 1 | 2022 | 1107 | 0.140 |
Why?
|
| Urogenital Abnormalities | 1 | 2019 | 261 | 0.140 |
Why?
|
| Epithelial Cells | 1 | 2008 | 3672 | 0.130 |
Why?
|
| Proteins | 1 | 2011 | 6030 | 0.130 |
Why?
|
| Receptors, Nicotinic | 1 | 2019 | 495 | 0.130 |
Why?
|
| Urinary Tract | 1 | 2019 | 313 | 0.130 |
Why?
|
| Anesthetics, Dissociative | 1 | 2016 | 80 | 0.130 |
Why?
|
| Urethane | 1 | 2015 | 36 | 0.130 |
Why?
|
| Oocytes | 1 | 2020 | 1166 | 0.130 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2020 | 894 | 0.120 |
Why?
|
| Rabbits | 2 | 2015 | 4770 | 0.120 |
Why?
|
| Hepatocytes | 1 | 2002 | 1231 | 0.120 |
Why?
|
| Calcium | 2 | 2020 | 5717 | 0.120 |
Why?
|
| Permeability | 1 | 2016 | 721 | 0.110 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2018 | 699 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 2057 | 0.110 |
Why?
|
| Estrenes | 1 | 2013 | 21 | 0.110 |
Why?
|
| Uridine Diphosphate | 1 | 2013 | 33 | 0.110 |
Why?
|
| Mechanical Phenomena | 1 | 2014 | 141 | 0.110 |
Why?
|
| Desmin | 1 | 2012 | 99 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2002 | 2291 | 0.100 |
Why?
|
| Pyrrolidinones | 1 | 2013 | 116 | 0.100 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 737 | 0.100 |
Why?
|
| Mucous Membrane | 1 | 2015 | 659 | 0.100 |
Why?
|
| Receptors, Purinergic P2X3 | 1 | 2011 | 9 | 0.100 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2012 | 183 | 0.100 |
Why?
|
| Vimentin | 1 | 2012 | 255 | 0.100 |
Why?
|
| Connexin 43 | 1 | 2012 | 200 | 0.100 |
Why?
|
| Tryptases | 1 | 2012 | 176 | 0.100 |
Why?
|
| Neurofibromin 2 | 1 | 2012 | 270 | 0.090 |
Why?
|
| Chloride Channels | 1 | 2012 | 221 | 0.090 |
Why?
|
| Mice, Inbred Strains | 1 | 2014 | 1759 | 0.090 |
Why?
|
| Environment | 1 | 2017 | 1123 | 0.090 |
Why?
|
| Cell Polarity | 1 | 2014 | 635 | 0.090 |
Why?
|
| Models, Animal | 1 | 2017 | 2109 | 0.090 |
Why?
|
| Antigens, CD34 | 1 | 2012 | 658 | 0.090 |
Why?
|
| Apyrase | 1 | 2013 | 373 | 0.090 |
Why?
|
| Species Specificity | 1 | 2014 | 2411 | 0.080 |
Why?
|
| Liver Neoplasms | 2 | 2002 | 4308 | 0.080 |
Why?
|
| Mesoderm | 1 | 2012 | 674 | 0.080 |
Why?
|
| Electric Stimulation | 1 | 2014 | 1734 | 0.080 |
Why?
|
| Models, Biological | 2 | 2019 | 9461 | 0.080 |
Why?
|
| Microscopy, Confocal | 2 | 2013 | 1970 | 0.080 |
Why?
|
| Hydrostatic Pressure | 1 | 2008 | 98 | 0.080 |
Why?
|
| Female | 10 | 2021 | 392148 | 0.080 |
Why?
|
| Blood Glucose | 1 | 2022 | 6390 | 0.070 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 1900 | 0.070 |
Why?
|
| DNA Primers | 1 | 2011 | 2817 | 0.070 |
Why?
|
| Ion Channel Gating | 1 | 2008 | 429 | 0.070 |
Why?
|
| Electrophysiology | 1 | 2008 | 1262 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10432 | 0.060 |
Why?
|
| Rats | 3 | 2010 | 23717 | 0.060 |
Why?
|
| Endocytosis | 1 | 2008 | 955 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4570 | 0.060 |
Why?
|
| Ion Channels | 1 | 2008 | 1039 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2019 | 18937 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 11874 | 0.050 |
Why?
|
| Cytochalasin D | 1 | 2002 | 91 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2013 | 3998 | 0.050 |
Why?
|
| Collagen Type IV | 1 | 2002 | 126 | 0.050 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2002 | 110 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2006 | 2261 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2017 | 4488 | 0.050 |
Why?
|
| Membranes, Artificial | 1 | 2002 | 366 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2011 | 5863 | 0.050 |
Why?
|
| Colchicine | 1 | 2002 | 259 | 0.040 |
Why?
|
| Vinblastine | 1 | 2002 | 488 | 0.040 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2002 | 311 | 0.040 |
Why?
|
| Elasticity | 1 | 2002 | 655 | 0.040 |
Why?
|
| Base Sequence | 1 | 2011 | 12421 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 8166 | 0.040 |
Why?
|
| Humans | 7 | 2022 | 760617 | 0.040 |
Why?
|
| Cell Adhesion | 2 | 2002 | 3088 | 0.040 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2002 | 620 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 11069 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 6126 | 0.040 |
Why?
|
| Pregnancy | 1 | 2019 | 29868 | 0.040 |
Why?
|
| Cell Cycle | 2 | 2002 | 2930 | 0.030 |
Why?
|
| Phenotype | 1 | 2014 | 16571 | 0.030 |
Why?
|
| Mutation | 1 | 2019 | 30016 | 0.030 |
Why?
|
| Protamines | 1 | 2014 | 112 | 0.030 |
Why?
|
| Neurons | 1 | 2012 | 9438 | 0.030 |
Why?
|
| Pedigree | 1 | 2019 | 4539 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 1827 | 0.020 |
Why?
|
| Male | 4 | 2019 | 360358 | 0.020 |
Why?
|
| Actins | 1 | 2014 | 2050 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 2915 | 0.020 |
Why?
|
| Basement Membrane | 1 | 2002 | 349 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2002 | 659 | 0.010 |
Why?
|
| S Phase | 1 | 2002 | 421 | 0.010 |
Why?
|
| G1 Phase | 1 | 2002 | 403 | 0.010 |
Why?
|
| Sex Factors | 1 | 2015 | 10548 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 29600 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39063 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 20074 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 59179 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 220969 | 0.000 |
Why?
|
| Time Factors | 1 | 2002 | 39913 | 0.000 |
Why?
|
Concepts
(150)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_